Epsilogen Ltd.
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Holding
- Established
- 2016-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.epsilogen.com
A Study of MOv18 IgE in Folate Receptor Alpha-expressing Platinum Resistant Ovarian Cancer
Phase 1
Recruiting
- Conditions
- Advanced Ovarian CancerPlatinum-resistant Ovarian Cancer
- Interventions
- First Posted Date
- 2024-08-09
- Last Posted Date
- 2024-12-20
- Lead Sponsor
- Epsilogen Ltd
- Target Recruit Count
- 45
- Registration Number
- NCT06547840
- Locations
- 🇬🇧
Guy's Hospital, London, United Kingdom
🇬🇧Bristol Haematology and Oncology Centre, Bristol, United Kingdom
🇬🇧Edinburgh Cancer Research Centre, Edinburgh, United Kingdom
© Copyright 2025. All Rights Reserved by MedPath